Clinical TrialsSearch results
Number of results: 71136
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Therapeutic use of Z-521
- primary hypophosphatemic rickets
- Zeria Pharmaceutical Co., Ltd.
- 2010-11-02
Other
- Z-103 Phase III Clinical Study in patients with Taste Disorder - A placebo-controlled superiority study -
- taste disorders induced by zinc-deficiency
- Zeria Pharmaceutical Co., Ltd.
- 2012-07-23
Other
- ZO-SA0 PhaseIII clinical trial
- Cardiovascular disease
- Zeria Pharmaceutical Co., Ltd.
- 2014-01-06
Other
- ZilvEr PTX for tHe Femoral ArterY and Proximal Popliteal ArteRy. -Prospective multicenter registry-
- Peripheral artery disease
- ZEPHYR Study Group
- 2012-07-13
Other
- Novel DCB for Coronary Artery Disease Trial
- Coronary Artery Disease
- Zeon Medical Inc. Business Development Depertment
- 2019-04-05
Other
- Rituxan injection drug use-results survey in ABO-incompatible kidney transplantation recipients
- ABO-incompatible kidney transplantation
- Zenyaku Kogyo, Co., Ltd.
- 2016-09-01
Other
- Rituxan injection drug use-results survey in ABO-incompatible liver transplantation recipients
- ABO-incompatible liver transplantation
- Zenyaku Kogyo, Co., Ltd.
- 2016-03-07
Other
- Rituxan injection drug use-results survey in patients with complicated nephrotic syndrome
- nephrotic symdrome
- Zenyaku Kogyo, Co., Ltd.
- 2014-08-29
Other
- A multicenter phase II open-label study in untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma evaluating efficacy and safety of maintenance therapy with IDEC-C2B8.
- Untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma.
- Zenyaku Kogyo Co., Ltd.
- 2008-12-26